4//SEC Filing
Lapidus Stanley 4
Accession 0001062993-22-019850
CIK 0001799011other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 11:46 AM ET
Size
6.3 KB
Accession
0001062993-22-019850
Insider Transaction Report
Form 4
Lapidus Stanley
Director
Transactions
- Sale
Common stock
2022-09-20$1.70/sh−16,864$28,669→ 135,456 total - Sale
Common stock
2022-09-20$1.71/sh−17,000$29,014→ 152,320 total
Footnotes (2)
- [F1]Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
- [F2]Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.
Issuer
Lucid Diagnostics Inc.
CIK 0001799011
Entity typeother
Related Parties
1- filerCIK 0001678195
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 11:46 AM ET
- Size
- 6.3 KB